Mechanisms of ceramide‐mediated repression of the human telomerase reverse transcriptase promoter via deacetylation of Sp3 by histone deacetylase 1

No abstract is available for this paper.

• Publication year

  2007

• Venue

  The FASEB Journal

• Publication date

  2007-10-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1096/fj.07-8621comPMID 17548428
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ceramide recruits and activates protein kinase C zeta (PKC zeta) within structured membrane microdomains.

  2007cited by this paper
• Ceramide kinase regulates growth and survival of A549 human lung adenocarcinoma cells

  2007cited by this paper
• Role of human longevity assurance gene 1 and C18-ceramide in chemotherapy-induced cell death in human head and neck squamous cell carcinomas

  2007cited by this paper
• The modification of Sp3 isoforms by SUMOylation has differential effects on the SRC1A promoter.

  2006cited by this paper
• Transcriptional repression of telomerase RNA gene expression by c-Jun-NH2-kinase and Sp1/Sp3.

  2006cited by this paper
• When Do Lasses (Longevity Assurance Genes) Become CerS (Ceramide Synthases)?

  2006cited by this paper
• A virus-encoded telomerase RNA promotes malignant T cell lymphomagenesis

  2006cited by this paper
• Necessary Role for the Lag1p Motif in (Dihydro)ceramide Synthase Activity*

  2006cited by this paper
• Function of AP-1 in Transcription of the Telomerase Reverse Transcriptase Gene (TERT) in Human and Mouse Cells

  2005cited by this paper
• The telomerase reverse transcriptase regulates chromatin state and DNA damage responses.

  2005cited by this paper
• Tumor necrosis factor-alpha inhibits hTERT gene expression in human myeloid normal and leukemic cells.

  2005cited by this paper
• The ins and outs of sphingolipid synthesis.

  2005cited by this paper
• Substrate specificity of human ceramide kinase Published, JLR Papers in Press, September 18, 2005. DOI 10.1194/jlr.M500313-JLR200

  2005cited by this paper
• Mechanism of telomerase repression during terminal differentiation of normal epithelial cells and squamous carcinoma lines.

  2005cited by this paper
• Differential cis-regulation of human versus mouse TERT gene expression in vivo: identification of a human-specific repressive element.

  2005cited by this paper
• Sp1/Sp3-dependent Regulation of Human Telomerase Reverse Transcriptase Promoter Activity by the Bioactive Sphingolipid Ceramide*

  2005cited by this paper
• Ceramide‐1‐phosphate promotes cell survival through activation of the phosphatidylinositol 3‐kinase/protein kinase B pathway

  2005cited by this paper
• Sumoylation of internally initiated Sp3 isoforms regulates transcriptional repression via a Trichostatin A-insensitive mechanism.

  2005cited by this paper
• Substrate specificity of human ceramide kinase

  2005cited by this paper
• Defects in Cell Growth Regulation by C18:0-Ceramide and Longevity Assurance Gene 1 in Human Head and Neck Squamous Cell Carcinomas*

  2004cited by this paper
• Restoration of Transforming Growth Factor-β Signaling through Receptor RI Induction by Histone Deacetylase Activity Inhibition in Breast Cancer Cells*

  2004cited by this paper
• Rapid Inhibition of Cancer Cell Growth Induced by Lentiviral Delivery and Expression of Mutant-Template Telomerase RNA and Anti-telomerase Short-Interfering RNA

  2004cited by this paper
• Identification and Characterization of a Novel p300-mediated p53 Acetylation Site, Lysine 305*

  2003cited by this paper
• Evidence for a Relief of Repression Mechanism for Activation of the Human Telomerase Reverse Transcriptase Promoter*

  2003cited by this paper
• Raft ceramide in molecular medicine

  2003cited by this paper
• Telomerase maintains telomere structure in normal human cells.

  2003cited by this paper
• Reciprocal regulation of expression of the human adenosine 5'-triphosphate binding cassette, sub-family A, transporter 2 (ABCA2) promoter by the early growth response-1 (EGR-1) and Sp-family transcription factors.

  2003cited by this paper
• Transcriptional regulation of the telomerase hTERT gene as a target for cellular and viral oncogenic mechanisms.

  2003cited by this paper
• Biochemical Mechanisms of the Generation of Endogenous Long Chain Ceramide in Response to Exogenous Short Chain Ceramide in the A549 Human Lung Adenocarcinoma Cell Line

  2002cited by this paper
• Upstream of Growth and Differentiation Factor 1 (uog1), a Mammalian Homolog of the Yeast Longevity Assurance Gene 1 (LAG1), RegulatesN-Stearoyl-sphinganine (C18-(Dihydro)ceramide) Synthesis in a Fumonisin B1-independent Manner in Mammalian Cells*

  2002cited by this paper
• Sp1 and Sp3 Recruit Histone Deacetylase to Repress Transcription of Human Telomerase Reverse Transcriptase (hTERT) Promoter in Normal Human Somatic Cells*

  2002cited by this paper
• The histone deacetylase inhibitor trichostatin A derepresses the telomerase reverse transcriptase (hTERT) gene in human cells.

  2002cited by this paper
• Molecular Mechanisms of Ceramide-mediated Telomerase Inhibition in the A549 Human Lung Adenocarcinoma Cell Line*

  2001cited by this paper
• Transcription factor Sp3 is regulated by acetylation.

  2001cited by this paper
• Competitive recruitment of CBP and Rb-HDAC regulates UBF acetylation and ribosomal transcription.

  2000cited by this paper
• Identification and characterization of negative regulatory elements of the human telomerase catalytic subunit (hTERT) gene promoter: possible role of MZF-2 in transcriptional repression of hTERT

  2000cited by this paper
• Regulation of E2F1 activity by acetylation

  2000cited by this paper
• Acetylation: a regulatory modification to rival phosphorylation?

  2000cited by this paper
• Cloning and characterization of the promoter region of human telomerase reverse transcriptase gene.

  1999cited by this paper
• Negative regulation of MDR1 promoter activity in MCF-7, but not in multidrug resistant MCF-7/Adr, cells by cross-coupled NF-kappa B/p65 and c-Fos transcription factors and their interaction with the CAAT region.

  1999cited by this paper
• Creation of human tumour cells with defined genetic elements

  1999cited by this paper
• Homologs of the yeast longevity gene LAG1 in Caenorhabditis elegans and human.

  1998cited by this paper
• Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT

  1997cited by this paper
• A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis

  1989cited by this paper

• Glucosylceramide Synthase, a Key Enzyme in Sphingolipid Metabolism, Regulates Expression of Genes Accounting for Cancer Drug Resistance

  2025cites this paper
• How ceramides affect the development of colon cancer: from normal colon to carcinoma

  2024cites this paper
• The role of ceranib-2 and its nanoform on the decrease of telomerase levels in human non-small cell cancer

  2024cites this paper
• Role of Ceramide in Remodeling of Skeletal Muscle Myosin Phenotype during Disuse: Possible Mechanisms

  2024cites this paper
• Metabolic signatures of combined exercise and fasting: an expanded perspective on previous telomere length findings

  2024cites this paper
• Epigenetic Regulation Mediated by Sphingolipids in Cancer

  2023cites this paper
• Drug Targeting of Acyltransferases in the Triacylglyceride and 1-O-AcylCeramide Biosynthetic Pathways

  2023cites this paper
• Proteomics-based trapping with single or multiple inactive mutants reproducibly profiles histone deacetylase 1 substrates.

  2022cites this paper
• Reprogrammed Lipid Metabolism and the Lipid-Associated Hallmarks of Colorectal Cancer

  2022cites this paper
• Ceramides: correlation with cardiovascular risk factors

  2022cites this paper
• Circulating ceramides as biomarkers of cardiovascular disease: Evidence from phenotypic and genomic studies.

  2021cites this paper
• S1P signaling, its interactions and cross-talks with other partners and therapeutic importance in colorectal cancer.

  2021cites this paper
• Onset of Senescence and Steatosis in Hepatocytes as a Consequence of a Shift in the Diacylglycerol/Ceramide Balance at the Plasma Membrane

  2021cites this paper
• Aging-dependent mitochondrial dysfunction mediated by ceramide signaling inhibits antitumor T cell response

  2021influential citation
• Lipidomics of aging

  2021cites this paper
• How do sphingolipids play a role in epigenetic mechanisms and gene expression?

  2021cites this paper
• Comparative sphingolipidomic analysis reveals significant differences between doxorubicin-sensitive and -resistance MCF-7 cells

  2021cites this paper
• White Matter Injury Is Associated with Reduced Manual Dexterity and Elevated Serum Ceramides in Subjects with Cerebral Small Vessel Disease.

  2020cites this paper
• Alteration of Sphingolipids in Biofluids: Implications for Neurodegenerative Diseases

  2019cites this paper
• Lipid mechanisms in hallmarks of cancer.

  2019cites this paper
• Mitochondrial Ceramide in Stroke

  2019cites this paper
• Ceramide synthases in cancer therapy and chemoresistance.

  2019cites this paper
• Ceramide Domains in Health and Disease: A Biophysical Perspective.

  2019cites this paper
• Expression of the SNAI2 transcriptional repressor is regulated by C16-ceramide

  2019cites this paper
• Ceramide synthases in cancer therapy and chemoresistance.

  2019cites this paper
• Regulation of Telomerase Activity

  2018cites this paper
• Modulation of Telomerase Activity in Cancer Cells by Dietary Compounds: A Review

  2018cites this paper
• Sphingolipids at the Crossroads of NAFLD and Senescence: CHAPTER SIX

  2018cites this paper
• [pemetrexed + sildenafil], via autophagy-dependent HDAC downregulation, enhances the immunotherapy response of NSCLC cells

  2017cites this paper
• Transcription Regulation of the Human Telomerase Reverse Transcriptase (hTERT) Gene

  2016influential citation
• Carnitine palmitoyltransferase 1C: From cognition to cancer.

  2016cites this paper
• The Human Microcirculation: Regulation of Flow and Beyond.

  2016cites this paper
• The enigma of ceramide synthase regulation in mammalian cells.

  2016cites this paper
• Manipulation of host nuclear function by Chlamydia trachomatis

  2016cites this paper
• Gutterman et al Regulation of the Human Microcirculation 159 Microcirculation as a Window Into Conduit Artery Disease and Cardiovascular Events

  2015cites this paper
• Sphingolipids as Mediators of Breast Cancer Progression, Metastasis, Response and Resistance to Chemotherapy

  2015cites this paper
• Binding of the sphingolipid S1P to hTERT stabilizes telomerase at the nuclear periphery by allosterically mimicking protein phosphorylation

  2015cites this paper
• Mathematical Model of a Telomerase Transcriptional Regulatory Network Developed by Cell-Based Screening: Analysis of Inhibitor Effects and Telomerase Expression Mechanisms

  2014cites this paper
• Elevation of Ceramide in Senescence: Role of Sphingolipid Metabolism

  2014cites this paper
• Hydroxyurea Resistance in Yeast the Candidate Lipid Mediator for -Phytoceramide as 18:1 Identification of C Lipids:

  2014cites this paper
• Enhancement of adriamycin cytotoxicity by sodium butyrate involves hTERT downmodulation‐mediated apoptosis in human uterine cancer cells

  2014cites this paper
• Identification of C18:1-Phytoceramide as the Candidate Lipid Mediator for Hydroxyurea Resistance in Yeast*

  2013cites this paper
• Chlamydia trachomatis inhibits telomeric DNA damage signaling via transient hTERT upregulation.

  2013cites this paper
• Ablation of very long acyl chain sphingolipids causes hepatic insulin resistance in mice due to altered detergent‐resistant membranes

  2013cites this paper
• Diverse functions of ceramide in cancer cell death and proliferation.

  2013cites this paper
• Sphingosine kinase/sphingosine 1-phosphate signaling in cancer therapeutics and drug resistance.

  2013cites this paper
• Ceramide function in the brain: when a slight tilt is enough

  2012cites this paper
• Ceramide synthases at the centre of sphingolipid metabolism and biology.

  2012cites this paper
• Sphingosine analogue drug FTY720 targets I2PP2A/SET and mediates lung tumour suppression via activation of PP2A-RIPK1-dependent necroptosis

  2012cites this paper
• Histone Deacetylase Inhibitors Restore Cell Surface Expression of the Coxsackie Adenovirus Receptor and Enhance CMV Promoter Activity in Castration-Resistant Prostate Cancer Cells

  2012cites this paper
• Endogenous modulators and pharmacological inhibitors of histone deacetylases in cancer therapy

  2012cites this paper
• Mitochondrial Ceramide in Stroke

  2012cites this paper
• Sphingolipids and expression regulation of genes in cancer.

  2011cites this paper
• Ceramidases in hematological malignancies: senseless or neglected target?

  2011cites this paper
• Sphingolipid signaling and hematopoietic malignancies: to the rheostat and beyond.

  2011cites this paper
• Development of a primary airway epithelial cell culture model and explanted tissue archive to study the role of neutrophilic inflammation and airway remodelling in cystic fibrosis lung disease

  2011influential citation
• Concerted functions of HDAC1 and microRNA-574-5p repress alternatively spliced ceramide synthase 1 expression in human cancer cells

  2011cites this paper
• Sphingolipid and Glycosphingolipid Metabolic Pathways in the Era of Sphingolipidomics

  2011cites this paper
• Developmentally Regulated Ceramide Synthase 6 Increases Mitochondrial Ca2+ Loading Capacity and Promotes Apoptosis*

  2010cites this paper
• Cancer treatment strategies targeting sphingolipid metabolism.

  2010cites this paper
• Sphingolipids and cancer: ceramide and sphingosine-1-phosphate in the regulation of cell death and drug resistance.

  2010cites this paper
• Chromatin remodeling: recruitment of histone demethylase RBP2 by Madl for transcriptional repression of a Myc target gene, telomerase reverse transcriptase

  2010cites this paper
• Human Glycolipid Transfer Protein Gene (GLTP) Expression Is Regulated by Sp1 and Sp3

  2010cites this paper
• Ceramide and Mitochondria in Ischemia/Reperfusion

  2009cites this paper
• HDAC3 represses the expression of NKG2D ligands ULBPs in epithelial tumour cells: potential implications for the immunosurveillance of cancer

  2009cites this paper
• Ceramide synthases and ceramide levels are increased in breast cancer tissue.

  2009cites this paper
• Direct interaction between the inhibitor 2 and ceramide via sphingolipid‐protein binding is involved in the regulation of protein phosphatase 2A activity and signaling

  2009cites this paper
• Transcription of the chicken Grin1 gene is regulated by the activity of SP3 and NRSF in undifferentiated cells and neurons.

  2008cites this paper
• Regulation of Telomere Length by Fatty Acid Elongase 3 in Yeast

  2008cites this paper
• Ceramide signaling in cancer and stem cells.

  2008cites this paper
• Deacetylases and NF-κB in Redox Regulation of Cigarette Smoke-Induced Lung Inflammation: Epigenetics in Pathogenesis of COPD

  2008cites this paper
• Roles of bioactive sphingolipids in cancer biology and therapeutics.

  2008cites this paper
• Clinical relevance of ceramide metabolism in the pathogenesis of human head and neck squamous cell carcinoma (HNSCC): attenuation of C(18)-ceramide in HNSCC tumors correlates with lymphovascular invasion and nodal metastasis.

  2007cites this paper
• Special Section on Therapeutic Implications for Sphingolipids in Health and Disease — Minireview Drug Targeting of Acyltransferases in the Triacylglyceride and 1-O-AcylCeramide Biosynthetic Pathways

  year unknowncites this paper